Paw Paw, MI, United States of America

Cara L Ruble

This inventor holds 1 USPTO granted patent. Top assignee: Pharmacia & Upjohn Company. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cara L Ruble. Retrieved from https://idiyas.com/inventor/cara-l-ruble

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Cara L. Ruble: Inventor in Ion Channel Research

Introduction

Cara L. Ruble is an inventor associated with Paw Paw, Michigan, and Pharmacia & Upjohn Company. Her patent work concerns human ion channel proteins and related methods with potential applications in biomedical research and treatment development.

Latest Patents

Ruble is named on 1 patent, titled “Human Ion Channel Proteins.” The invention describes novel ion channel polypeptides and the polynucleotides that encode them. It also covers expression vectors, host cells, and methods for producing the proteins. In addition, the patent describes methods for identifying ion channel agonists and antagonists, which may be useful in developing treatments for human diseases and conditions.

Career Highlights

Ruble’s documented patent contribution reflects work at the intersection of molecular biology and therapeutic research. The invention’s focus on ion channels and methods for identifying compounds that affect them connects foundational biological research with potential medical applications.

Collaborations

The patent lists Christopher W. Benjamin and Steven L. Roberds among Ruble’s coworkers. Their shared association with the invention reflects collaborative research in ion channel proteins and related technologies.

Conclusion

Cara L. Ruble’s patent record highlights a contribution to ion channel research, including technologies and methods with potential relevance to the study and treatment of human diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…